Table 4.
Evaluation of the association between XO and T2D.
| B | SE | Wald | Df | OR (95% Cl) | p-value | |
|---|---|---|---|---|---|---|
| Male | ||||||
| Model 1 | 0.334 | 0.085 | 15.479 | 1 | 1.396 (1.182–1.649) | 0.000 |
| Model 2 | 0.350 | 0.093 | 14.196 | 1 | 1.419 (1.183–1.702) | 0.000 |
| Model 3 | 0.468 | 0.133 | 12.403 | 1 | 1.597 (1.231–2.071) | 0.000 |
| Female | ||||||
| Model 1 | 0.342 | 0.149 | 5.265 | 1 | 1.408 (1.051–1.887) | 0.022 |
| Model 2 | 0.333 | 0.151 | 4.840 | 1 | 1.395 (1.037–1.878) | 0.028 |
| Model 3 | 0.700 | 0.310 | 5.095 | 1 | 2.014 (1.097–3.699) | 0.024 |
| Overall | ||||||
| Model 1 | 0.383 | 0.073 | 27.830 | 1 | 1.467 (1.272–1.692) | 0.000 |
| Model 2 | 0.354 | 0.076 | 21.543 | 1 | 1.424 (1.227–1.654) | 0.000 |
| Model 3 | 0.472 | 0.105 | 20.172 | 1 | 1.603 (1.304–1.969) | 0.000 |
Association between XO levels and T2D was determined by Multinomial logistic regression. The dependent variable was T2D (yes) and the independent variable was XO (U/L). The reference category is control (non-T2D).
Model 1: adjusted for age, BMI, SBP and DBP.
Model 2: model 1 + SUA.
Model 3: model 2 + lipid markers (TG, TC, HDL, LDL), SA, eGFR and smoking status.
OR odds ratio, CI confidence interval, SE standard error.